Pharmaceutical Industry Articles & Reports - Page 22

Analyze the future of Contract Research Organizations (CROs) to 2030. Learn about market growth forecasts, the impact of AI, and decentralized clinical trial mo

Explore the evolution from paper CRFs to eCRFs for clinical trials. Compare paper vs. electronic data capture (EDC) on data quality, cost, time, and compliance. Updated for 2026 with ICH E6(R3), AI-powered eCRF design, decentralized trials, and the latest EDC market trends.

Learn about the database lock process in clinical trials. Updated for ICH E6(R3) 2025. Covers data integrity, soft vs hard lock, AI-accelerated cleaning, RBQM compliance, and best practices

Learn the key factors CROs use for clinical trial site selection. This guide covers patient recruitment, feasibility assessments, and data-driven methods for su

Learn the complete query management process in clinical trials. This guide covers the workflow, high costs, and impact on data integrity for CROs and sites.

Explore the end-to-end Request for Proposal (RFP) process for clinical trial outsourcing. Learn best practices for sponsors to write and evaluate CRO bids, updated with ICH E6(R3) guidelines and 2025-2026 market data.

A detailed analysis of clinical trial start-up costs, from IRB fees to site activation. Explore 2025-2026 benchmarks, hidden expenses, AI-driven cost reduction, and budgeting strategies for sponsors and CROs

Compare ACRP vs. SOCRA clinical research certifications (updated April 2026). Covers ICH E6(R3) transition, eligibility, exam content, updated fees, and recertification for CCRC, CCRA & CCRP

Learn how to manage protocol deviations in clinical trials. Updated for ICH E6(R3) and FDA 2024 draft guidance, covering classification, reporting, and prevention for data integrity and GCP compliance.

Learn the key differences between an Adverse Event (AE), Serious AE (SAE), and SUSAR. Updated for 2026 with ICH E6(R3), EU CTR 536/2014 CTIS, FDA Dec 2025 guidances, and ICH E2B(R3) mandate. Covers definitions, causality, and expedited reporting timelines.

Learn what an Investigator's Brochure (IB) is, its required content per ICH GCP E6(R3) guidelines (finalized 2025), and its critical role in assessing risk for clinical trials.

Learn the essential CDISC standards for clinical trial data. This guide explains SDTM and ADaM data models, their structure, regulatory requirements, and 2025-2026 updates including SDTM v3.0, Dataset-JSON, and ICH M11.

Learn what decentralized clinical trials (DCTs) are, how they work, and the technology involved. Updated for 2026 with ICH E6(R3), FDA/EMA guidance updates, Trials@Home RADIAL results, and current market data. Covers benefits, challenges, regulatory landscape, and future of DCTs.

An evidence-based comparison of digital vs. traditional clinical trial recruitment updated for 2026, covering AI-powered patient matching, DCT market growth, FDA guidance, and hybrid recruitment strategies for diversity.

Prepare for FDA BIMO inspections with this updated 2026 guide for clinical sites & CROs. Covers ICH E6(R3), finalized BIMO guidance, RRAs, documentation, QMS, staff training, & GCP compliance.

Learn about the EU Clinical Trial Regulation (CTR) 536/2014 and the CTIS portal. This guide covers harmonized submission processes, key timelines, and transpare

Explore the critical role of an IRB/IEC in protecting human subjects. Learn how ethics committees review and approve clinical trials per key ethical regulations including ICH E6(R3), the 2024 Declaration of Helsinki, and EU CTIS requirements

Learn why patient retention is critical for clinical trial validity. Updated for 2026 with FDA DCT guidance, ICH E6(R3), AI engagement platforms, and evidence-based strategies to reduce dropouts

A detailed guide to the 13 principles of Good Clinical Practice (GCP). Understand the ICH E6(R2) and finalized E6(R3) standards for protecting subjects and ensuring data integrity.

Learn about clinical trial vendor management and how CROs ensure oversight of labs, logistics, and translation services per ICH E6(R3) GCP and regulatory standards. Updated for 2026 with the latest on ICH E6(R3) implementation, decentralized trial logistics, and AI-assisted translation.

Learn about informed consent forms (ICFs) in clinical trials. Updated for ICH E6(R3) 2025, eConsent innovations, and FDA/EU regulatory changes. Covers history, ethics, and patient autonomy.

An in-depth comparison of the FDA and EMA, updated for 2026. Learn the key differences in US and EU drug approval processes, review timelines, GMP, FDORA reforms, EU pharma legislation overhaul, and regulatory frameworks.

A comprehensive guide to the clinical trial protocol, updated for 2026 with ICH E6(R3) and ICH M11 developments. Learn its core components, importance in research, and how to manage complexity and amendments for successful trials.

Learn why the drug development timeline averages 10-15 years. Updated for 2026 with AI drug discovery milestones, ICH E6(R3), FDA AI guidance, and latest cost and success rate data. Covers every stage from discovery through approval.